$7.76
1.52% yesterday
Nasdaq, Apr 04, 10:00 pm CET
ISIN
US68401U2042
Symbol
OPRX

OptimizeRx Corporation Stock price

$7.75
+2.47 46.78% 1M
+0.21 2.79% 6M
+2.89 59.47% YTD
-3.46 30.87% 1Y
-32.47 80.73% 3Y
-0.91 10.51% 5Y
+4.03 108.33% 10Y
Nasdaq, Closing price Fri, Apr 04 2025
-0.13 1.65%
ISIN
US68401U2042
Symbol
OPRX
Industry

Key metrics

Market capitalization $143.30m
Enterprise Value $163.11m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 32.43
EV/Sales (TTM) EV/Sales 1.77
P/S ratio (TTM) P/S ratio 1.56
P/B ratio (TTM) P/B ratio 1.22
Revenue growth (TTM) Revenue growth 28.81%
Revenue (TTM) Revenue $92.13m
EBIT (operating result TTM) EBIT $-6.22m
Free Cash Flow (TTM) Free Cash Flow $5.03m
Cash position $13.38m
EPS (TTM) EPS $-1.10
P/E forward negative
P/S forward 1.42
EV/Sales forward 1.61
Short interest 9.70%
Show more

Is OptimizeRx Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

OptimizeRx Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a OptimizeRx Corporation forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a OptimizeRx Corporation forecast:

Buy
86%
Hold
14%

Financial data from OptimizeRx Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
92 92
29% 29%
100%
- Direct Costs 37 37
20% 20%
40%
55 55
36% 36%
60%
- Selling and Administrative Expenses 57 57
11% 11%
62%
- Research and Development Expense - -
-
-
-1.89 -1.89
83% 83%
-2%
- Depreciation and Amortization 4.33 4.33
80% 80%
5%
EBIT (Operating Income) EBIT -6.22 -6.22
53% 53%
-7%
Net Profit -20 -20
14% 14%
-22%

In millions USD.

Don't miss a Thing! We will send you all news about OptimizeRx Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

OptimizeRx Corporation Stock News

Neutral
Seeking Alpha
24 days ago
OptimizeRx Corporation (NASDAQ:OPRX ) Q4 2024 Results Conference Call March 12, 2025 8:30 AM ET Company Participants Steve Silvestro - President Edward Stelmakh - Chief Financial Officer and Chief Operational Officer Andrew D'Silva - Senior Vice President of Corporate Finance Conference Call Participants Jared Haase - William Blair Anderson Schock - B. Riley Constantine Davides - Citizens JMP R...
Neutral
GlobeNewsWire
24 days ago
WALTHAM, Mass., March 12, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced results for the fourth quarter and full year ended December 31, 2024.
Neutral
GlobeNewsWire
25 days ago
WALTHAM, Mass., March 11, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today confirmed that it has received a purported notice of nominations from a stockholder, Whetstone Capital Advisors, LLC, regarding its intention ...
More OptimizeRx Corporation News

Company Profile

OptimizeRx Corp. engages in the provision of digital health messaging via electronic health records, which serves as a direct channel for pharmaceutical companies to communicate with healthcare providers. It offers EHR workflow solutions which include financial messaging, patient education, and brand messaging; and brand support. The company was founded by David A. Harrell on November 8, 1985 and is headquartered in Rochester, MI.

Head office United States
CEO Stephen Silvestro
Employees 129
Founded 1985
Website www.optimizerx.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today